April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
In Vitro Silencing of TGFß1 and its Receptor 2 in a Human Corneal Epithelial Cell Line Using Cationized Gelatin/Chondroitin Sulphate Nanoparticles
Isabel Arranz-Valsero; Jenny E. Párraga; Laura Contreras-Ruiz; G K. Zorzi; Antonio López-García; Begoña Seijo; Alejandro Sánchez; Yolanda Diebold
Author Affiliations & Notes
  • Isabel Arranz-Valsero
    Ocular Surface Group, IOBA-University of Valladolid, Valladolid, Spain
    Networking Research Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain
  • Jenny E. Párraga
    NANOBIOFAR Group, Department of Pharmacy and Pharmaceutical Science, University of Santiago de Compostela, Santiago de Compostela, Spain
  • Laura Contreras-Ruiz
    Ocular Surface Group, IOBA-University of Valladolid, Valladolid, Spain
    Networking Research Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain
  • G K. Zorzi
    NANOBIOFAR Group, Department of Pharmacy and Pharmaceutical Science, University of Santiago de Compostela, Santiago de Compostela, Spain
  • Antonio López-García
    Ocular Surface Group, IOBA-University of Valladolid, Valladolid, Spain
    Networking Research Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain
  • Begoña Seijo
    NANOBIOFAR Group, Department of Pharmacy and Pharmaceutical Science, University of Santiago de Compostela, Santiago de Compostela, Spain
  • Alejandro Sánchez
    NANOBIOFAR Group, Department of Pharmacy and Pharmaceutical Science, University of Santiago de Compostela, Santiago de Compostela, Spain
  • Yolanda Diebold
    Ocular Surface Group, IOBA-University of Valladolid, Valladolid, Spain
    Networking Research Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain
  • Footnotes
    Commercial Relationships  Isabel Arranz-Valsero, None; Jenny E. Párraga, None; Laura Contreras-Ruiz, None; G. K. Zorzi, None; Antonio López-García, None; Begoña Seijo, None; Alejandro Sánchez, None; Yolanda Diebold, None
  • Footnotes
    Support  MAT2007-64626-C02-01/02, CIBER-BBN, FPU and FPI Scholarship Programs (Ministries of Science, Health and Education), JCyL Regional Scholarship Program, Spain. Program AlBan E07D402978BR (EU)
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 1429. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      In Vitro Silencing of TGFß1 and its Receptor 2 in a Human Corneal Epithelial Cell Line Using Cationized Gelatin/Chondroitin Sulphate Nanoparticles
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      Isabel Arranz-Valsero, Jenny E. Párraga, Laura Contreras-Ruiz, G K. Zorzi, Antonio López-García, Begoña Seijo, Alejandro Sánchez, Yolanda Diebold; In Vitro Silencing of TGFß1 and its Receptor 2 in a Human Corneal Epithelial Cell Line Using Cationized Gelatin/Chondroitin Sulphate Nanoparticles. Invest. Ophthalmol. Vis. Sci. 2011;52(14):1429.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : To silence in vitro the expression of the identified in ocular surface inflammatory disorders pro-inflammatory molecule TGFß1 and its Receptor 2 (TGFBR2), using cationized gelatine (CG)/chondroitin sulphate (CS) nanoparticles (NPs) as vehicle to deliver small interfering RNA (siRNA).

Methods: : NPs were prepared from CG and CS, using either spermine or ethylenediamine as cationizing agents (WO2010/049562A1), and loaded with specific or with mismatching siRNAs, at different concentrations (150 or 300nM). Cells from a Human Corneal Epithelial cell line (HCE) were transfected with siTGFß1- or siTGFBR2-loaded CG/CS NPs. Naked siRNAs were used as controls, and Lipofectamine was used as control transfection reagent. siRNA-loaded NPs internalization was evaluated using a Cy3-conjugated siGAPDH. Potential toxicity was evaluated by the XTT test. Levels of mRNA were determined by Real Time RT-PCR (RT²-PCR) and protein expression by ELISA or Western blot.

Results: : CG/CS NPs with the siRNA incorporated in their matrix had a diameter around 300nm. They were able to deliver siRNA into cell cytosol, as determined by fluorescence microscopy, while maintaining high cell viability. Decreased levels of TGFß1 and TGFBR2 mRNA were observed in HCE cells transfected with siRNA-NPs but not with blank NPs or with naked siRNAs, as determined by RT²-PCR. The silencing was also observed at the protein level for both molecules after siRNA-NPs transfection by ELISA or Western blotting.

Conclusions: : It is possible to silence TGFß1 and TGFBR2 expression in HCE cells by conventional techniques obtaining acceptable silencing levels while maintaining high cell viability. CG/CS NPs are promising new vehicles to deliver siRNA to human cells from the ocular surface as potential therapeutic option to treat inflammatory diseases.

Keywords: cornea: epithelium • gene transfer/gene therapy • inflammation 
© 2011, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2024 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept